Using Reporter Genes for Drug Screening Against Leishmania
Author Information
Author(s): Monte-Alegre Adriano, Ouaissi Ali, Sereno Denis
Primary Institution: IRD, UR008 "Pathogènie des Trypanosomatidés"
Hypothesis
Can reporter gene technology improve drug screening for Leishmania amastigotes?
Conclusion
The study suggests that reporter gene technology could enhance the sensitivity and reliability of drug screening against Leishmania amastigotes.
Supporting Evidence
- 12 million people are affected by leishmaniasis worldwide.
- Reporter gene technology can improve drug screening sensitivity and reliability.
- Various Leishmania species expressing reporter genes have been engineered for drug testing.
Takeaway
Scientists are trying to use special genes that glow to help find new medicines for a tiny bug that makes people sick.
Methodology
The study discusses the use of various reporter genes in Leishmania for drug screening and evaluates their effectiveness.
Potential Biases
Potential bias due to the variability in reporter gene expression and the influence of host cell background.
Limitations
The presence of antibiotic resistance and the biological consequences of transforming parasites may affect the results.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website